TW1 <GO>TARGET WATCH2 <GO>MARKETLIVE
API

Demant

Latest price
299.20 DKK
17/09/2026
Latest (1)
275.00 DKK
-8.09%
Upside
AVG (17)
300.00 DKK
+0.27%
Upside
Aligned
DEMANT
3 mo+0.27%17 price targets
6 mo-1.07%19 price targets
1 yr-2.91%20 price targets
Max 20 price targets
CitigroupExane BNP ParibasJyske BankBarclaysDNB CarnegieDeutsche BankSEBOddoBernsteinUBSDanske BankGoldman SachsMorgan StanleyHandelsbankenJP MorganNordeaEquita SIM
HealthcareMedical Devices

About The Company

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Yahoo Finance

Latest Target

The most recently set price target for the stock, from a single analyst.

Target
275.00 DKK
Upside
-8.09%
Latest price299.20 DKK

Three Month Consensus

The median of each house's latest target set within the last 90 days.

Consensus
300.00 DKK
Upside
+0.27%
Aligned17 houses · range 245.00 DKK–330.00 DKK · last 90 days
245.00 DKK330.00 DKK

line = latest price · dot = consensus

Latest price299.20 DKK

More Price Targets for Demant

Analyst
Hit rate 54 %
Date
Sep 18

Analyst
Hit rate 61 %
Date
Aug 20

Analyst
Hit rate 74 %
Date
Aug 19

Analyst
Hit rate 71 %
Date
Aug 13

Analyst
Hit rate 62 %
Date
Aug 13

Analyst
Hit rate 49 %
Date
Aug 13

Analyst
Hit rate 62 %
Date
Aug 13

Analyst
Hit rate 57 %
Date
Aug 13

Analyst
Hit rate 58 %
Date
Aug 13

Analyst
Hit rate 51 %
Date
Aug 12

Analyst
Hit rate 56 %
Date
Aug 12

Analyst
Hit rate 50 %
Date
Aug 4

Analyst
Hit rate 62 %
Date
Jul 28

Analyst
Hit rate 71 %
Date
Jul 23

Analyst
Hit rate 61 %
Date
Jul 22

Analyst
Hit rate 44 %
Date
Jul 17

Analyst
Date
Jul 2

Date
Jun 9

Analyst
Hit rate 63 %
Date
Apr 29

Analyst
Hit rate 63 %
Date
Mar 18